Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.3517
-0.0293 (-7.69%)
Mar 31, 2025, 1:24 PM EDT - Market open
Passage Bio Employees
Passage Bio had 60 employees as of December 31, 2024. The number of employees increased by 2 or 3.45% compared to the previous year.
Employees
60
Change (1Y)
2
Growth (1Y)
3.45%
Revenue / Employee
n/a
Profits / Employee
-$1,079,450
Market Cap
21.86M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PASG News
- 27 days ago - Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 4 weeks ago - Passage Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates - GlobeNewsWire
- 5 months ago - Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire
- 5 months ago - Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference - GlobeNewsWire
- 6 months ago - Passage Bio to Present at Chardan's 8th Annual Genetic Medicines Conference - GlobeNewsWire
- 7 months ago - Passage Bio Welcomes Tom Kassberg to Board of Directors - GlobeNewsWire
- 7 months ago - Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire